Last reviewed · How we verify

Caudal block with levobupivacaine

University of Novi Sad · Phase 3 active Small molecule

Levobupivacaine administered via caudal block provides regional anesthesia by blocking sodium channels in nerve fibers, preventing pain signal transmission to the central nervous system.

Levobupivacaine administered via caudal block provides regional anesthesia by blocking sodium channels in nerve fibers, preventing pain signal transmission to the central nervous system. Used for Regional anesthesia via caudal epidural block for surgical procedures, Pain management in pediatric and adult patients.

At a glance

Generic nameCaudal block with levobupivacaine
SponsorUniversity of Novi Sad
Drug classLocal anesthetic
TargetVoltage-gated sodium channels
ModalitySmall molecule
Therapeutic areaAnesthesia
PhasePhase 3

Mechanism of action

Levobupivacaine is the S-enantiomer of bupivacaine, a local anesthetic that reversibly inhibits sodium influx through voltage-gated sodium channels in nerve cell membranes. When delivered via caudal epidural injection, it anesthetizes sacral and lower lumbar nerve roots, providing regional anesthesia for surgical procedures and pain management. The S-enantiomer formulation offers improved cardiac safety compared to racemic bupivacaine.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results